Lantheus Holdings (FRA:0L8) Total Liabilities: €981 Mil (As of Mar. 2026)

What is Lantheus Holdings Total Liabilities?

Lantheus Holdings FRA:0L8 +3.79% 82 Total Liabilities is €981 Mil as of Mar. 2026. GuruFocus rates FRA:0L8 with a GF Score™ of 82/100 and a GF Value™ of €79.79 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Lantheus Holdings's Total Liabilities for the quarter that ended in Mar. 2026 was €981 Mil.

Lantheus Holdings's quarterly Total Liabilities declined from Sep. 2025 (€985.93 Mil) to Dec. 2025 (€971.51 Mil) but then increased from Dec. 2025 (€971.51 Mil) to Mar. 2026 (€981.17 Mil).

Lantheus Holdings's annual Total Liabilities increased from Dec. 2023 (€765.93 Mil) to Dec. 2024 (€852.17 Mil) and increased from Dec. 2024 (€852.17 Mil) to Dec. 2025 (€971.51 Mil).

Lantheus Holdings Total Liabilities Related Terms

Lantheus Holdings Total Liabilities Historical Data

* Premium members only.

The historical data trend for Lantheus Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lantheus Holdings Total Liabilities Chart

Lantheus Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

353.42

825.16

765.93

852.17

971.51

Lantheus Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Liabilities	Get a 7-Day Free Trial															824.20	823.04	985.93	971.51	981.17

82GF Score

Lantheus Holdings Inc FRA:0L8

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Lantheus Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lantheus Holdings's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	284.74	+	(528.365	+	112.081
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	46.326	+	0	+	0)
	=	972

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	1902.199	-	930.687
	=	972

Lantheus Holdings's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	288.189	+	(540.581	+	106.115
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	46.284	+	0	+	0)
	=	981

Total Liabilities	=	Total Assets (Q: Mar. 2026 )	-	Total Equity (Q: Mar. 2026 )
	=	2029.798	-	1048.629
	=	981

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of €981 Mil mean?

Lantheus Holdings (FRA:0L8) has a Total Liabilities of €981 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lantheus Holdings and its competitors.

Is Lantheus Holdings' Total Liabilities too high?

Lantheus Holdings' current Total Liabilities is €981 Mil. Overall, Lantheus Holdings has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Lantheus Holdings' Total Liabilities compare to LQDA and HIMS?

Lantheus Holdings' Total Liabilities of €981 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Drug Manufacturers company?

A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lantheus Holdings and its competitors. Lantheus Holdings's current Total Liabilities is €981 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Lantheus Holdings stock overvalued right now?

Based on GuruFocus' analysis, Lantheus Holdings (FRA:0L8) is currently considered Modestly Overvalued. The stock's GF Value™ is €79.79, compared to a current price of €93.20 — trading 16.8% above its estimated fair value. The current Total Liabilities is €981 Mil. Lantheus Holdings' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Lantheus Holdings (FRA:0L8), the current Total Liabilities is €981 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lantheus Holdings (FRA:0L8) Overvalued in 2026?

Based on GuruFocus' analysis, Lantheus Holdings stock appears to be overvalued. The current stock price of €93.20 is trading 16.8% above its estimated GF Value™ of €79.79. GuruFocus considers Lantheus Holdings to be Modestly Overvalued.

Key valuation signals for FRA:0L8:

Total Liabilities: €981 Mil
GF Value™: €79.79 vs. price of €93.20 (16.8% above fair value)
GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the FRA:0L8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lantheus Holdings Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies LQDA HIMS AMRX ALKS INDV KNSA RGC SUPN BCRX PBH XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges LNTH:USA 1LNTH:Italy 0L8:Germany

Address 201 Burlington Road, South Building, Bedford, MA, USA, 01730

Website https://www.lantheus.com

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

82GF Score

Get the complete analysis for FRA:0L8

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€93.20

Price

€79.79

GF Value

View FRA:0L8 Analysis

See Total Liabilities data for all stocks →